LBH589 reduces oxidized mitochondrial DNA and suppresses NLRP3 inflammasome activation to relieve pulmonary inflammation
PLOS One · 2025
DOI: 10.1371/journal.pone.0328522 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Changwen Ning und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Service and Transfusion Medicine, Academy of Military Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, DNA, Mitochondrial, Pneumonia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The NOD-like receptor protein (NLRP)3 inflammasome plays a critical role in acute respiratory distress syndrome (ARDS) by activating caspase-1, which cleaves the precursor forms of IL-1β and IL-18 into active cytokines and induces pyroptosis by cleaving gasdermin D (GSDMD). LBH589, a pan-histone deacetylase inhibitor, exhibits promising anti-inflammatory and immunomodulatory properties. However, the protective effect and underlying mechanism of LBH589 against ARDS is still unclear. In this study, we aim to determine whether and how LBH589 inhibits NLRP3 inflammasome activation while exerting its anti-inflammatory effect. Our data demonstrated that LBH589 effectively suppressed NLRP3 inflammasome activation in lipopolysaccharides (LPS)-primed and adenosine triphosphate (ATP)-stimulated J774A.1 cells and bone marrow-derived macrophages (BMDMs), evidenced by attenuated cleaved caspase-1 and IL-1β, IL-18, IL-16 release, as along with reduced GSDMD-mediated pyroptosis and ASC speck formation. Additionally, LBH589 significantly decreased mitochondrial reactive oxygen species (mtROS) and oxidized mitochondrial DNA (Ox-mtDNA), key triggers of inflammasome activation. Importantly, both prophylactic and therapeutic administration of LBH589 inhibited the pro-inflammatory cytokines secretion in lung tissue and ameliorated lipopolysaccharide (LPS)-induced ARDS in mice. These findings suggest that LBH589 may provide therapeutic benefits in ARDS by attenuating NLRP3 inflammasome activation and pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Health Service and Transfusion Medicine, Academy of Military Medical Sciences, Beijing, China.
ORCID-Profile: Qun Yu
Zitieren
APA
Ning, C., Gao, F., Wang, Z., An, H., Liu, P., Sun, Y., Li, R., Song, Z., Yuan, Y., Li, J., Ma, J., Jiang, X., & Yu, Q. (2025). LBH589 reduces oxidized mitochondrial DNA and suppresses NLRP3 inflammasome activation to relieve pulmonary inflammation. PLOS One. https://doi.org/10.1371/journal.pone.0328522
Vancouver
Ning C, Gao F, Wang Z, An H, Liu P, Sun Y, et al. LBH589 reduces oxidized mitochondrial DNA and suppresses NLRP3 inflammasome activation to relieve pulmonary inflammation. PLOS One. 2025. doi:10.1371/journal.pone.0328522
BibTeX
@article{Ning2025,
author = {Ning, Changwen and Gao, Fenghua and Wang, Zhe and An, Huaying and Liu, Pengyu and Sun, Yanan and Li, Ru and Song, Zhuyang and Yuan, Yuanyuan and Li, Jinlong and Ma, Jun and Jiang, Xingwei and Yu, Qun},
title = {LBH589 reduces oxidized mitochondrial DNA and suppresses NLRP3 inflammasome activation to relieve pulmonary inflammation},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328522}
}
EUVIMED